3-(Phenylimino)-2-indolinone; 2-INDOLINONE, 3-(PHENYLIMINO)-; (3E)-3-(phenylimino)-1,3-dihydro-2H-indol-2-one; 2H-Inden-2-one, 1,3-dihydro-3-(phenylimino)-; MLS002920119; CHEMBL227491; (E)-3-(Phenylimino)indolin-2-one; 3-(phenylimino)indolin-2-one; 3-(phenylazamethylene)-1H-benzo[d]azolin-2-one; NSC 131622; AI3-51432; 1,3-Dihydro-3-(phenylimino)-2H-indol-2-one; 2H-Indol-2-one, 1,3-dihydro-3-(phenylimino)-; NSC131622; Enamine_005045; 3-phenyliminoindolin-2-one; 3-phenylimino-2-oxoindoline; Oprea1_869175; ARONIS019248; CTK1C3943; DTXSID50187476; HMS1408F07; 2-Indolinone, 3- (phenylimino)-; ALBB-016882; KS-00004B8X; (Z)-3-(phenylimino)indolin-2-one; BDBM50198047; CCG-55254; MFCD00859189; SBB083404; STK010013; ZINC13465608; (E/Z)-3-(phenylimino)indolin-2-one; AKOS000486085; AKOS003236137; MCULE-3573008446; NSC-131622; IDI1_007632; 3-(Phenylimino)-1H-indole-2(3H)-one; SMR001797716; R3916; ST45033109; 2H-Inden-2-one,3-dihydro-3-(phenylimino)-; 2H-Indol-2-one,3-dihydro-3-(phenylimino)-; 3-(phenylimino)-1,3-dihydro-2H-indol-2-one; SR-01000644289-1; (3Z)-3-(Phenylimino)-1,3-dihydro-2H-indol-2-one; (3Z)-3-(Phenylimino)-1,3-dihydro-2H-indol-2-one #; 2H-Indol-2-one, 1,3-dihydro-3-(phenylimino)- (9CI); 2H-indol-2-one, 1,3-dihydro-3-(phenylimino)-, (3E)-